US5744347A
(en)
*
|
1987-01-16 |
1998-04-28 |
Ohio University Edison Biotechnology Institute |
Yolk sac stem cells and their uses
|
US5399493A
(en)
*
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
US5605822A
(en)
*
|
1989-06-15 |
1997-02-25 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for growing human hematopoietic cells
|
US5763266A
(en)
*
|
1989-06-15 |
1998-06-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
|
US5635386A
(en)
|
1989-06-15 |
1997-06-03 |
The Regents Of The University Of Michigan |
Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
|
US5061620A
(en)
*
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
US5635387A
(en)
*
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
US5840580A
(en)
*
|
1990-05-01 |
1998-11-24 |
Becton Dickinson And Company |
Phenotypic characterization of the hematopoietic stem cell
|
US5622853A
(en)
*
|
1990-05-01 |
1997-04-22 |
Becton Dickinson And Company |
T lymphocyte precursor
|
US6631842B1
(en)
*
|
2000-06-07 |
2003-10-14 |
Metrologic Instruments, Inc. |
Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US6010696A
(en)
*
|
1990-11-16 |
2000-01-04 |
Osiris Therapeutics, Inc. |
Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
|
US5348859A
(en)
*
|
1990-11-23 |
1994-09-20 |
Coulter Corporation |
Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
|
US5340719A
(en)
*
|
1990-11-23 |
1994-08-23 |
Corporation Coulter |
Method and apparatus for optically screening microscopic cells
|
US5464753A
(en)
*
|
1991-03-08 |
1995-11-07 |
Univ Illinois |
Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
|
US5994088A
(en)
|
1991-03-08 |
1999-11-30 |
Board Of Trustees Of The University Of Illinois |
Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5367057A
(en)
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
JP3213314B2
(ja)
*
|
1991-04-05 |
2001-10-02 |
ボード・オブ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・ワシントン |
幹細胞因子レセプターに対するモノクローナル抗体
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
WO1992018615A1
(en)
|
1991-04-09 |
1992-10-29 |
Indiana University Foundation |
System and process for supporting hematopoietic cells
|
JPH07501206A
(ja)
*
|
1991-08-07 |
1995-02-09 |
イェシバ・ユニバーシティ |
前駆肝細胞の増殖
|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
NL9101680A
(nl)
*
|
1991-10-04 |
1993-05-03 |
Tno |
Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
|
DK0614485T3
(da)
*
|
1991-10-23 |
2002-10-28 |
Nexell Therapeutics Inc |
Fremgangsmåde til selektiv formering af CD34 positive celler
|
CA2122140A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Dale R. Peterson |
Method for freezing engrafting cells
|
US6353150B1
(en)
*
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
WO1993018136A1
(en)
*
|
1992-03-05 |
1993-09-16 |
Cytomed, Inc. |
Process for supporting hematopoietic progenitor cells
|
JPH06508528A
(ja)
*
|
1992-03-23 |
1994-09-29 |
ネクセル セラピューティクス インコーポレーテッド |
インビトロ由来ヒト好中球前駆体細胞
|
US5888499A
(en)
*
|
1992-03-23 |
1999-03-30 |
Nexell Therapeutics Inc. |
Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
IL106295A
(en)
*
|
1992-07-10 |
2001-03-19 |
Univ Pittsburgh |
Hematopoietic facilitaroy cells
|
SG55145A1
(en)
*
|
1992-07-10 |
1998-12-21 |
Univ Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
AU678988B2
(en)
*
|
1992-07-27 |
1997-06-19 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
US5589376A
(en)
*
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
US5849553A
(en)
*
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
US5654183A
(en)
*
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
US5928947A
(en)
*
|
1992-07-27 |
1999-07-27 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
CA2141428A1
(en)
*
|
1992-07-28 |
1994-02-03 |
Steven Kessler |
Methods for positive immunoselection of stem cells
|
CA2080255A1
(en)
*
|
1992-07-31 |
1994-02-01 |
Connie J. Eaves |
Primitive hematopoietic stem cell preparations
|
US5466572A
(en)
*
|
1992-09-03 |
1995-11-14 |
Systemix, Inc. |
High speed flow cytometric separation of viable cells
|
WO1994005775A1
(en)
*
|
1992-09-03 |
1994-03-17 |
Systemix, Inc. |
High speed flow cytometric separation of viable mammalian cells
|
US5342776A
(en)
*
|
1992-09-04 |
1994-08-30 |
Bolnet Marie C N |
Avian hemopoietic progenitor cells
|
WO1994008039A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
US5766951A
(en)
*
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
DE69309487T2
(de)
*
|
1992-11-13 |
1997-10-23 |
Univ Washington |
Peripheralisierung hämatopoietischer stammzellen
|
SG86980A1
(en)
*
|
1992-11-16 |
2002-03-19 |
Applied Immunesciences |
Pluripotential quiescent stem cell population
|
US5409710A
(en)
*
|
1993-04-20 |
1995-04-25 |
Endocon, Inc. |
Foam cell drug delivery
|
JPH08509720A
(ja)
*
|
1993-05-03 |
1996-10-15 |
ジェネンテク、インコーポレイテッド |
白血球接着阻害
|
NZ314644A
(en)
|
1993-05-24 |
2000-11-24 |
Immunex Corp |
Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
|
US5554512A
(en)
*
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
JP4236279B2
(ja)
*
|
1993-05-24 |
2009-03-11 |
ズィメレックス・インコーポレーテッド |
異種移植に対する寛容性の発現のための代理寛容形成
|
US5772994A
(en)
*
|
1993-05-28 |
1998-06-30 |
The University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
US6033906A
(en)
*
|
1993-07-26 |
2000-03-07 |
California Institute Of Technology |
Methods for differentiating neural stem cells to glial cells using neuregulins
|
WO1995003693A1
(en)
*
|
1993-07-29 |
1995-02-09 |
Systemix, Inc. |
Novel stem cell marker
|
AU685506B2
(en)
*
|
1993-08-25 |
1998-01-22 |
Systemix, Inc. |
Method for producing a highly enriched population of hematopoietic stem cells
|
EP0722489B1
(de)
*
|
1993-09-08 |
2002-04-03 |
Imclone Systems, Inc. |
Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
|
WO1995008105A1
(en)
*
|
1993-09-17 |
1995-03-23 |
Systemix, Inc. |
Method for obtaining a cell population enriched in stem cells and compositions derived therefrom
|
US5409813A
(en)
*
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
US5599703A
(en)
*
|
1993-10-28 |
1997-02-04 |
The United States Of America As Represented By The Secretary Of The Navy |
In vitro amplification/expansion of CD34+ stem and progenitor cells
|
US6190655B1
(en)
|
1993-12-03 |
2001-02-20 |
Immunex Corporation |
Methods of using Flt-3 ligand for exogenous gene transfer
|
DE69533504D1
(de)
*
|
1994-01-05 |
2004-10-21 |
Univ Pittsburgh Pittsburgh |
Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
|
US6001654A
(en)
*
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US20030108545A1
(en)
*
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
US7294331B2
(en)
*
|
1994-03-07 |
2007-11-13 |
Immunex Corporation |
Methods of using flt3-ligand in hematopoietic cell transplantation
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
US5972627A
(en)
*
|
1994-06-15 |
1999-10-26 |
Systemix, Inc. |
Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
|
US5985660A
(en)
*
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
AU2158295A
(en)
*
|
1994-06-15 |
1996-01-05 |
Systemix, Inc. |
Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using
|
US5972703A
(en)
*
|
1994-08-12 |
1999-10-26 |
The Regents Of The University Of Michigan |
Bone precursor cells: compositions and methods
|
US5474687A
(en)
*
|
1994-08-31 |
1995-12-12 |
Activated Cell Therapy, Inc. |
Methods for enriching CD34+ human hematopoietic progenitor cells
|
US5827742A
(en)
*
|
1994-09-01 |
1998-10-27 |
Beth Israel Deaconess Medical Center, Inc. |
Method of selecting pluripotent hematopioetic progenitor cells
|
US6140119A
(en)
*
|
1994-09-16 |
2000-10-31 |
Michigan State University |
Expression of estrogen receptors in type I and type II human breast epithelial cells
|
US5650317A
(en)
*
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
US5686577A
(en)
*
|
1994-10-17 |
1997-11-11 |
Cornell Research Foundation, Inc. |
T cell factors influencing B cell development
|
US5665557A
(en)
*
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
US5677136A
(en)
*
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
AU4254396A
(en)
*
|
1994-11-14 |
1996-06-06 |
Novartis Ag |
Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
|
US5610056A
(en)
*
|
1994-11-16 |
1997-03-11 |
Amgen Inc. |
Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells
|
US5874301A
(en)
*
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
US5665350A
(en)
*
|
1994-11-23 |
1997-09-09 |
University Of Massachusetts Medical Center |
Cell cycle dependent transplantation and ex vivo gene therapy
|
WO1996016674A1
(en)
*
|
1994-12-01 |
1996-06-06 |
New England Deaconess Hospital Corporation |
In vitro t-lymphopoiesis system
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
GB9502022D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Abuljadayel Ilham M S |
A method for preparing lymphohaematopoietic progenitor cells
|
US9068164B1
(en)
*
|
1995-02-02 |
2015-06-30 |
Tristem Trading (Cyprus) Limited |
Method of preparing an undifferentiated cell
|
US5830755A
(en)
*
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
US5876956A
(en)
*
|
1995-05-15 |
1999-03-02 |
Johns Hopkins University School Of Medicine |
Methods for identification or purification of cells containing an enzymatic intracellular marker
|
US5925567A
(en)
*
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
US5674750A
(en)
*
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
US6015554A
(en)
*
|
1995-06-07 |
2000-01-18 |
Systemix, Inc. |
Method of reconstituting human lymphoid and dendritic cells
|
WO1996040875A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Novartis Ag |
Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
US7361330B2
(en)
*
|
1995-10-04 |
2008-04-22 |
Immunex Corporation |
Methods of using flt3-ligand in the treatment of fibrosarcoma
|
US20020034517A1
(en)
*
|
1995-10-04 |
2002-03-21 |
Kenneth Brasel |
Dendritic cell stimulatory factor
|
US7150992B1
(en)
|
1995-10-04 |
2006-12-19 |
Innunex Corporation |
Methods of preparing dendritic cells with flt3-ligand and antigen
|
US6060052A
(en)
*
|
1995-10-30 |
2000-05-09 |
Systemix, Inc. |
Methods for use of Mpl ligands with primitive human hematopoietic stem cells
|
US5910434A
(en)
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
AU1430997A
(en)
*
|
1995-12-19 |
1997-07-14 |
Systemix, Inc. |
Primate cluster-forming embryonic hematopoietic stem cells
|
JP2000503542A
(ja)
*
|
1996-01-16 |
2000-03-28 |
デピュイ オーソピーディック,インコーポレイテッド |
造血及び非造血組織からの前駆細胞の分離及び in vivo 骨及び軟骨再生におけるそれらの使用
|
EP0891419A4
(de)
*
|
1996-03-12 |
2000-03-01 |
Life Technologies Inc |
Nährstoffzusatz für hematopoetische zellkulturen
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US5928638A
(en)
*
|
1996-06-17 |
1999-07-27 |
Systemix, Inc. |
Methods for gene transfer
|
DE69733694T2
(de)
*
|
1996-07-10 |
2006-07-06 |
Muramatsu, Takashi, Nagoya |
Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
AU740709B2
(en)
*
|
1996-08-19 |
2001-11-15 |
University Of Massachusetts |
Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
US6043348A
(en)
*
|
1996-11-13 |
2000-03-28 |
Lawman; Michael J. P. |
Antibody recognizing a small subset of human hematopoietic cells
|
JP2001505906A
(ja)
*
|
1996-12-10 |
2001-05-08 |
ハダジット メディカル リサーチ サービシズ アンド ディベラップメント カンパニー リミテッド |
細胞の分化を誘導する血清由来因子およびその医薬的使用
|
AU6536698A
(en)
*
|
1997-02-24 |
1998-09-09 |
Tm Technologies, Inc. |
Anti-sense oligonucleotide pharmacological agents
|
US6331406B1
(en)
*
|
1997-03-31 |
2001-12-18 |
The John Hopkins University School Of Medicine |
Human enbryonic germ cell and methods of use
|
US6090622A
(en)
*
|
1997-03-31 |
2000-07-18 |
The Johns Hopkins School Of Medicine |
Human embryonic pluripotent germ cells
|
US5948426A
(en)
*
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
AU9472998A
(en)
*
|
1997-09-04 |
1999-03-22 |
Science Research Laboratory, Inc. |
Cell separation using electric fields
|
US6440734B1
(en)
*
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
US6093531A
(en)
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US5955257A
(en)
|
1997-10-21 |
1999-09-21 |
Regents Of The University Of Minnesota |
Infusible grade short-term cell storage medium for mononuclear cells
|
US6734338B1
(en)
|
1997-11-14 |
2004-05-11 |
Cedars-Sinai Medical Center |
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
|
AU761758B2
(en)
*
|
1997-11-14 |
2003-06-12 |
Cedars-Sinai Medical Center |
Transfection and transfer of male germ cells for generation of transgenic species
|
US7294755B1
(en)
|
1997-11-14 |
2007-11-13 |
Cedars-Sinai Medical Center |
Genetic modification of male germ cells for generation of transgenic species and genetic therapies
|
US6361642B1
(en)
|
1997-12-02 |
2002-03-26 |
Baxter International Inc. |
Heat and pressure-formed flexible containers
|
JP2001525176A
(ja)
*
|
1997-12-04 |
2001-12-11 |
デューク・ユニバーシティー |
Cd7+cd34−lin−造血細胞を単離し、使用する方法
|
US6059968A
(en)
*
|
1998-01-20 |
2000-05-09 |
Baxter International Inc. |
Systems for processing and storing placenta/umbilical cord blood
|
WO1999037751A1
(en)
*
|
1998-01-23 |
1999-07-29 |
Imclone Systems Incorporated |
Purified populations of stem cells
|
US20020034819A1
(en)
*
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
ES2316187T3
(es)
|
1998-05-29 |
2009-04-01 |
Case Western Reserve University |
Transduccion de genes en celulas progenitoras hematopoyeticas.
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
JP2002523039A
(ja)
*
|
1998-08-24 |
2002-07-30 |
ティー.ブリーダーズ,インコーポレイテッド |
非胎児血管芽細胞を含む細胞集団、およびその生産方法
|
AU5448099A
(en)
*
|
1998-09-02 |
2000-03-27 |
Chugai Seiyaku Kabushiki Kaisha |
Method for preparing cell fraction containing hematopoietic stem cells
|
US8297377B2
(en)
*
|
1998-11-20 |
2012-10-30 |
Vitruvian Exploration, Llc |
Method and system for accessing subterranean deposits from the surface and tools therefor
|
DK1975243T3
(da)
*
|
1998-12-07 |
2010-06-28 |
Univ Duke |
BODIPY-aminoacetaldehyddiethylacetal
|
WO2000043499A2
(en)
*
|
1999-01-25 |
2000-07-27 |
Seattle Biomedical Research Institute |
ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
|
ATE284220T1
(de)
|
1999-02-03 |
2004-12-15 |
Idm Immuno Designed Molecules |
Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode
|
US6153113A
(en)
*
|
1999-02-22 |
2000-11-28 |
Cobe Laboratories, Inc. |
Method for using ligands in particle separation
|
US6238922B1
(en)
|
1999-02-26 |
2001-05-29 |
Stemcells, Inc. |
Use of collagenase in the preparation of neural stem cell cultures
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
US6455311B1
(en)
*
|
1999-04-30 |
2002-09-24 |
The General Hospital Corporation |
Fabrication of vascularized tissue
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US6821513B1
(en)
|
1999-06-23 |
2004-11-23 |
Oregon Health & Science University |
Method for enhancing hematopoiesis
|
WO2000078930A1
(en)
*
|
1999-06-23 |
2000-12-28 |
Oregon Health Sciences University |
Method for enhancing hematopoiesis
|
US8252280B1
(en)
|
1999-08-05 |
2012-08-28 |
Regents Of The University Of Minnesota |
MAPC generation of muscle
|
US7015037B1
(en)
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
US10638734B2
(en)
|
2004-01-05 |
2020-05-05 |
Abt Holding Company |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
ATE514772T1
(de)
|
1999-08-05 |
2011-07-15 |
Abt Holding Co |
Multipotente erwachsene stammzellen und verfahren zu deren isolierung
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
US6749850B1
(en)
|
1999-08-18 |
2004-06-15 |
The General Hospital Corporation |
Methods, compositions and kits for promoting recovery from damage to the central nervous system
|
CA2385628A1
(en)
*
|
1999-09-27 |
2001-04-05 |
Ammon B. Peck |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
AU1778001A
(en)
*
|
1999-11-17 |
2001-05-30 |
University Of Rochester |
Human ex vivo immune system
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
US7112576B1
(en)
|
1999-12-10 |
2006-09-26 |
Regents Of The University Of Minnesota |
Compositions and methods for cryopreservation of peripheral blood lymphocytes
|
NZ519346A
(en)
*
|
1999-12-20 |
2004-02-27 |
Univ Massachusetts |
Embryonic or stem-like cells produced by cross species nuclear transplantation
|
AU4744201A
(en)
*
|
2000-03-15 |
2001-09-24 |
Childrens Medical Center |
Systemic gene delivery vehicles for the treatment of tumors
|
US20020098524A1
(en)
*
|
2000-04-14 |
2002-07-25 |
Murray Christopher J. |
Methods for selective targeting
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
US7776021B2
(en)
*
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
US8491884B2
(en)
|
2000-05-03 |
2013-07-23 |
Oncolytics Biotech Inc. |
Virus clearance of neoplastic cells from mixed cellular compositions
|
AR028040A1
(es)
*
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
|
AR028039A1
(es)
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
|
US6828145B2
(en)
*
|
2000-05-10 |
2004-12-07 |
Cedars-Sinai Medical Center |
Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
|
WO2001094420A1
(en)
*
|
2000-06-05 |
2001-12-13 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
FR2810045B1
(fr)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
|
US6632620B1
(en)
*
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
US8044259B2
(en)
*
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
EP1978090A1
(de)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pankreatische Vorläuferzellen
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
WO2002057428A1
(en)
*
|
2000-10-30 |
2002-07-25 |
University Of Massachusetts |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
WO2002044343A2
(en)
*
|
2000-11-22 |
2002-06-06 |
Geron Corporation |
Tolerizing allografts of pluripotent stem cells
|
US6576464B2
(en)
*
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
US6921665B2
(en)
*
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
AU2002219987A1
(en)
*
|
2000-12-01 |
2002-06-11 |
The General Hospital Corporation |
Methods and products for manipulating hematopoietic stem cells
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
WO2002046373A1
(en)
*
|
2000-12-06 |
2002-06-13 |
Hariri Robert J |
Method of collecting placental stem cells
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
US20030049689A1
(en)
*
|
2000-12-14 |
2003-03-13 |
Cynthia Edwards |
Multifunctional polypeptides
|
US20030147874A1
(en)
*
|
2000-12-14 |
2003-08-07 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
US20080248544A1
(en)
*
|
2000-12-14 |
2008-10-09 |
Murray Christopher J |
Methods And Compositions For Grafting Functional Loops Into A Protein
|
US20030068792A1
(en)
*
|
2000-12-14 |
2003-04-10 |
Yiyou Chen |
Targeted enzymes
|
US20040033218A1
(en)
*
|
2000-12-19 |
2004-02-19 |
Oron Yacoby-Zeevi |
Use of ecm degrading enzymes for the improvement of cell transplantation
|
AU2002239810A1
(en)
|
2001-01-02 |
2002-07-16 |
The Charles Stark Draper Laboratory, Inc. |
Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
|
EP2336299A1
(de)
*
|
2001-02-14 |
2011-06-22 |
Anthrogenesis Corporation |
Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
|
EP1491093B1
(de)
*
|
2001-02-14 |
2013-07-31 |
ABT Holding Company |
Multipotente adulte Stammzellen, ausgangsmaterial dafür, verfahren zu ihrer Gewinnung und Erhaltung, Differenzierungsmethoden dafür, verfahren zu ihrer Verwendung, sowie von ihnen stammende Zellen
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
FR2821947B1
(fr)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
Procede et dispositif de validation de parametres definissant une image
|
JP2004526449A
(ja)
*
|
2001-03-29 |
2004-09-02 |
イクシオン・バイオテクノロジー・インコーポレーテッド |
非膵性幹細胞の膵分化経路への分化転換法
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
JP4493882B2
(ja)
*
|
2001-06-19 |
2010-06-30 |
株式会社カネカ |
抗原およびこの抗原を識別するモノクローナル抗体
|
EP1515707A4
(de)
*
|
2001-06-20 |
2005-10-19 |
Imclone Systems Inc |
Verfahren zur behandlung von atherosklerose und anderer entzündlicher erkrankungen
|
CA2454251A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Imclone Systems Incorporated |
Isolation and mobilization of stem cells expressing vegfr-1
|
US20030049836A1
(en)
*
|
2001-08-15 |
2003-03-13 |
Phi-Wilson Janette T. |
Cell separation system
|
DE10144326B4
(de)
*
|
2001-09-10 |
2005-09-22 |
Siemens Ag |
Verfahren und System zur Überwachung eines Reifenluftdrucks
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
US9969980B2
(en)
*
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
WO2003027247A2
(en)
|
2001-09-24 |
2003-04-03 |
Sangamo Biosciences, Inc. |
Modulation of stem cells using zinc finger proteins
|
US20030119080A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Mangano Joseph A. |
Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
|
US7129034B2
(en)
*
|
2001-10-25 |
2006-10-31 |
Cedars-Sinai Medical Center |
Differentiation of whole bone marrow
|
US6759244B2
(en)
|
2001-11-08 |
2004-07-06 |
Art Institute Of New York And New Jersey, Inc. |
Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
|
EP2292734A1
(de)
|
2001-12-07 |
2011-03-09 |
Geron Corporation |
Hämatopoietische Zellen aus menschlichen Embryostammzellen
|
JP2005511754A
(ja)
*
|
2001-12-07 |
2005-04-28 |
リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
乳癌幹細胞の予測的同定および特徴づけ
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
PT1916001E
(pt)
*
|
2002-03-04 |
2011-07-18 |
Imclone Llc |
Anticorpos humanos específicos para kdr e suas utilizações
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
US20030215935A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Coon David James |
Apparatus and method for isolating living cells from an encapsulated organ tissue sample
|
SI1458853T1
(sl)
*
|
2002-05-16 |
2010-04-30 |
Absorber Ab |
Postopki donorsko specifiŽŤnega navzkriĹľnega ujemanja
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
US20060088838A1
(en)
|
2002-06-12 |
2006-04-27 |
Murray Christopher J |
Methods for improving a binding characteristic of a molecule
|
AU2003247135A1
(en)
*
|
2002-07-23 |
2004-02-09 |
Nanodiagnostics, Inc. |
Embryonic stem cell markers and uses thereof
|
US20110158966A1
(en)
*
|
2002-07-23 |
2011-06-30 |
Judith Seligman |
Stem cells characterized by expression of germline specific genes
|
WO2007116408A2
(en)
*
|
2006-04-11 |
2007-10-18 |
Nanodiagnostics Israel Ltd. |
Pluripotent stem cells characterized by expression of germline specific genes
|
US7635477B2
(en)
*
|
2002-07-25 |
2009-12-22 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
EP1545603B1
(de)
*
|
2002-07-25 |
2015-09-16 |
The General Hospital Corporation |
Parathyreoidhormon-rezeptor-aktivierung und expansion von hämatopoetischen vorläuferzellen
|
US20040028661A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Bartelmez Stephen H. |
Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
|
IL166636A0
(en)
*
|
2002-08-09 |
2006-01-15 |
Innovationsagentur |
Method for producing cell lines and organs by means of differentiable cells
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
US20040077985A1
(en)
*
|
2002-09-03 |
2004-04-22 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US20040044300A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US9969977B2
(en)
*
|
2002-09-20 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
JP4939055B2
(ja)
|
2002-11-13 |
2012-05-23 |
トマス ジェファソン ユニバーシティ |
癌の診断および治療のための組成物および方法
|
AU2003295444A1
(en)
*
|
2002-11-15 |
2004-06-15 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
EP1571910A4
(de)
|
2002-11-26 |
2009-10-28 |
Anthrogenesis Corp |
Zytotherapeutika, zytotherapeutischeeinheiten und behandlungsverfahren, bei denen diese verwendet werden
|
US20040110286A1
(en)
*
|
2002-12-06 |
2004-06-10 |
The John P. Robarts Research Institute |
Method for making hematopoietic cells
|
WO2004065616A2
(en)
|
2003-01-16 |
2004-08-05 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
NZ542127A
(en)
*
|
2003-02-13 |
2008-04-30 |
Anthrogenesis Corp |
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
|
US20070020242A1
(en)
*
|
2003-03-27 |
2007-01-25 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
|
EP1636351A4
(de)
|
2003-05-21 |
2007-04-04 |
Gen Hospital Corp |
Mikrofabrizierte zusammensetzungen und verfahren zur konstruktion von geweben mit mehreren zellarten
|
CA2528669A1
(en)
*
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
AU2004320466A1
(en)
*
|
2003-06-11 |
2006-02-02 |
Jan Remmereit |
Nuclear reprogramming of cells for therapeutic use
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US20060162014A1
(en)
*
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US8153410B2
(en)
*
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
WO2005014791A2
(en)
|
2003-08-08 |
2005-02-17 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
WO2005017117A2
(en)
*
|
2003-08-14 |
2005-02-24 |
Martin Haas |
Multipotent amniotic fetal stem cells (mafsc) and banking of same
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
WO2005027841A2
(en)
*
|
2003-09-16 |
2005-03-31 |
University Of North Carolina At Chapel Hill |
Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
|
US7510877B2
(en)
*
|
2003-09-26 |
2009-03-31 |
The Regents Of The University Of Michigan |
Hematopoietic stem cell identification and isolation
|
JP2007509042A
(ja)
*
|
2003-09-29 |
2007-04-12 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
造血前駆細胞の接着、分化および遊走を変化させるための方法
|
US20070141703A1
(en)
*
|
2003-11-19 |
2007-06-21 |
Stanley Edouard G |
Methods for producing blood products from pluripotent cells in cell culture
|
CN101966183A
(zh)
*
|
2003-12-02 |
2011-02-09 |
细胞基因公司 |
用于治疗和控制血红蛋白病和贫血病的方法和组合物
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
AU2005209169B2
(en)
|
2004-01-16 |
2010-12-16 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
WO2005074633A2
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
EP1718735A1
(de)
*
|
2004-02-11 |
2006-11-08 |
Aldagen, Inc. |
Stammzellpopulationen und verwendungsverfahren
|
ATE481477T1
(de)
*
|
2004-03-09 |
2010-10-15 |
Absorber Ab |
Endothelvorläuferzellen und verfahren zur verwendung davon
|
ATE480550T1
(de)
|
2004-03-25 |
2010-09-15 |
California Inst Of Techn |
Hybridisierungskettenreaktion
|
ATE506431T1
(de)
*
|
2004-04-23 |
2011-05-15 |
Bioe Llc |
Mehrfachlinien-vorläuferzellen
|
US7622108B2
(en)
*
|
2004-04-23 |
2009-11-24 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
US20050265980A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
US20080233100A1
(en)
*
|
2004-06-30 |
2008-09-25 |
Yiyou Chen |
Targeted enzymes
|
JP2008505650A
(ja)
*
|
2004-07-12 |
2008-02-28 |
ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ |
ヒト細胞を増殖させるための装置及び方法
|
ATE452987T1
(de)
*
|
2004-09-10 |
2010-01-15 |
Genencor Int |
Verfahren zur erkennung von zielen
|
EP1800136B1
(de)
*
|
2004-10-15 |
2011-12-07 |
Danisco US Inc. |
Kompetitven differential screening
|
WO2007001420A2
(en)
*
|
2004-10-22 |
2007-01-04 |
Genencor International, Inc. |
Isolating human antibodies
|
ZA200704252B
(en)
|
2004-10-25 |
2009-09-30 |
Cellerant Therapeutics Inc |
Methods of expanding myeloid cell populations and uses thereof
|
AU2005304687B2
(en)
|
2004-11-11 |
2012-01-19 |
The General Hosptial Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
JP4864900B2
(ja)
|
2004-11-18 |
2012-02-01 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
血管内皮成長因子受容体−iに対する抗体
|
US20080044400A1
(en)
*
|
2004-12-09 |
2008-02-21 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
GB0503918D0
(en)
*
|
2005-02-25 |
2005-04-06 |
Erasmus University |
Cell
|
US7727721B2
(en)
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
US20060269527A1
(en)
*
|
2005-05-26 |
2006-11-30 |
Australian Stem Cell Centre Limited |
Isolation of cells from bone
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
EP1907858A4
(de)
*
|
2005-06-13 |
2009-04-08 |
Univ Michigan |
Zusammensetzungen und verfahren zur behandlung und diagnose von krebs
|
CN101273141B
(zh)
|
2005-07-26 |
2013-03-27 |
桑格摩生物科学股份有限公司 |
外源核酸序列的靶向整合和表达
|
US7601699B2
(en)
*
|
2005-08-01 |
2009-10-13 |
Nupotential, Inc. |
Production of reprogrammed cells with restored potential
|
EP1924606A4
(de)
|
2005-08-25 |
2010-01-13 |
Repair Technologies Inc |
Vorrichtungen, zusammensetzungen und verfahren zum schutz und zur reparatur von zellen und gewebe
|
WO2008020815A1
(en)
|
2006-08-15 |
2008-02-21 |
Agency For Science, Technology And Research |
Mesenchymal stem cell conditioned medium
|
CN101296702B
(zh)
|
2005-09-12 |
2012-11-28 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
US7462485B2
(en)
*
|
2005-10-07 |
2008-12-09 |
Glaser Lawrence F |
Modified erythrocytes and uses thereof
|
ATE526975T1
(de)
|
2005-10-07 |
2011-10-15 |
California Inst Of Techn |
Pkr-aktivierung mittels hybridisierungskettenreaktion
|
WO2007047468A2
(en)
|
2005-10-13 |
2007-04-26 |
Anthrogenesis Corporation |
Immunomodulation using placental stem cells
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
AU2006344359B2
(en)
|
2005-10-31 |
2013-08-15 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
PT1951864E
(pt)
*
|
2005-11-07 |
2014-08-27 |
Amorcyte Inc |
Composições e métodos de reparação de lesões vasculares
|
CN101573441A
(zh)
|
2005-12-08 |
2009-11-04 |
路易斯维尔大学研究基金会有限公司 |
非常小的胚胎样(vsel)干细胞及分离和利用其的方法
|
US9155762B2
(en)
*
|
2005-12-08 |
2015-10-13 |
University Of Louisville Research Foundation, Inc. |
Uses and isolation of stem cells from bone marrow
|
NZ595786A
(en)
*
|
2005-12-29 |
2013-05-31 |
Anthrogenesis Corp |
Placental stem cell populations
|
ZA200804718B
(en)
|
2005-12-29 |
2010-04-28 |
Anthrogenesis Corp |
Co-culture of placental stem cells and stem cells from a second source
|
AU2007214468B2
(en)
*
|
2006-02-14 |
2013-04-04 |
Cellerant Therapeutics, Inc. |
Methods and compositions for enhancing engraftment of hematopoietic stem cells
|
CA2644922C
(en)
|
2006-03-07 |
2019-07-23 |
Geeta Shroff |
Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
|
EP2010646A2
(de)
*
|
2006-04-14 |
2009-01-07 |
Carnegie Mellon University |
Zellbeschriftung und -quantifizierung für nukleare magnetresonanzverfahren
|
JP2009533061A
(ja)
*
|
2006-04-14 |
2009-09-17 |
セルセンス, インコーポレイテッド |
細胞の標識を評価する方法
|
EP2019858B1
(de)
*
|
2006-04-17 |
2012-06-13 |
BioE LLC |
Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
|
EP2656832B1
(de)
*
|
2006-05-11 |
2018-12-19 |
Regenics AS |
Zusammensetzungen zur Verwendung in der Wundheilung
|
US20080050814A1
(en)
*
|
2006-06-05 |
2008-02-28 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
WO2007146105A2
(en)
*
|
2006-06-05 |
2007-12-21 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
US8785193B2
(en)
|
2006-09-14 |
2014-07-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Dissection tool and methods of use
|
US20120269774A1
(en)
*
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
WO2008039874A2
(en)
|
2006-09-26 |
2008-04-03 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
WO2008066658A2
(en)
*
|
2006-11-03 |
2008-06-05 |
The Trustees Of Princeton University |
Engineered cellular pathways for programmed autoregulation of differentiation
|
DE602007012290D1
(de)
*
|
2006-11-03 |
2011-03-10 |
Aastrom Biosciences Inc |
Mischzell-populationen für die gewebereparatur und trenntechnik für die zellaufbereitung
|
US9005964B2
(en)
*
|
2006-11-24 |
2015-04-14 |
Regents Of The University Of Minnesota |
Endodermal progenitor cells
|
WO2008070861A2
(en)
*
|
2006-12-07 |
2008-06-12 |
Cellerant Therapeutics Inc. |
Methods and compositions for treating systemic lupus erythematosus
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
JP2010516240A
(ja)
|
2007-01-18 |
2010-05-20 |
スオメン プナイネン リスティ,ヴェリパルベル |
ヒト細胞からの新規の炭水化物、ならびにその分析および修飾のための方法
|
US20100068806A1
(en)
|
2007-01-18 |
2010-03-18 |
Suomen Punainen Risti, Veripalvelu |
Novel methods and reagents directed to production of cells
|
EP2106439B1
(de)
|
2007-01-24 |
2014-11-12 |
The Regents of the University of Michigan |
Zusammensetzungen und verfahren zur behandlung und diagnostizierung von pankreaskrebs
|
EP2630959A1
(de)
|
2007-02-12 |
2013-08-28 |
Anthrogenesis Corporation |
Behandlung von Infektionskrankheiten mithilfe von Plazenta-Stammzellen
|
EP2129775A1
(de)
*
|
2007-02-12 |
2009-12-09 |
Anthrogenesis Corporation |
Hepatocyten und chondrocyten aus adhärenten plazentastammzellen sowie cd34+, cd45- plazentastammzellenangereicherte zellpopulationen
|
DK2918598T3
(en)
|
2007-02-28 |
2019-04-29 |
The Govt Of U S A As Represented By The Secretary Of The Dept Of Health And Human Services |
Brachyury polypeptides and methods of use
|
WO2008106658A2
(en)
*
|
2007-03-01 |
2008-09-04 |
California Institute Of Technology |
TRIGGERED RNAi
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
WO2008137115A1
(en)
|
2007-05-03 |
2008-11-13 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
WO2008137641A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Whitehead Institute For Biomedical Research |
Ex vivo expansion of human hematopoietic stem cells
|
EP2155770B1
(de)
|
2007-05-16 |
2013-10-16 |
California Institute of Technology |
Vielseitiges nukleinsäure-haarnadel-motiv zur programmierung biomolekularer selbstanordnungspfade
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
CA2690143A1
(en)
*
|
2007-06-15 |
2008-12-24 |
Garnet Biotherapeutics Inc. |
Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
|
CA2693678C
(en)
*
|
2007-07-10 |
2017-02-14 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
CN101835479A
(zh)
*
|
2007-07-25 |
2010-09-15 |
佰欧益有限公司 |
多系祖细胞分化为软骨细胞
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
WO2009042201A1
(en)
*
|
2007-09-26 |
2009-04-02 |
Celgene Cellular Therapeutics |
Angiogenic cells from human placental perfusate
|
KR20230065354A
(ko)
|
2007-09-28 |
2023-05-11 |
셀룰래리티 인코포레이티드 |
인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
|
WO2009058983A2
(en)
*
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
CN101978046A
(zh)
*
|
2007-10-30 |
2011-02-16 |
路易斯维尔大学研究基金会有限公司 |
非常小的胚胎样(vsel)干细胞的应用和分离
|
WO2009061447A2
(en)
*
|
2007-11-07 |
2009-05-14 |
Anthrogenesis Corporation |
Treatment of premature birth complications
|
JP5889533B2
(ja)
|
2008-01-31 |
2016-03-22 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
改変された抗体定常ドメイン分子
|
US8497364B2
(en)
*
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
WO2009116951A2
(en)
|
2008-03-17 |
2009-09-24 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
WO2009120368A2
(en)
|
2008-03-28 |
2009-10-01 |
Stemcyte, Inc. |
Treatment of brain damage using umbilical cord blood cells
|
AU2009241762B2
(en)
*
|
2008-05-02 |
2015-07-16 |
Celsense Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
ES2613965T3
(es)
*
|
2008-05-09 |
2017-05-29 |
Regenics As |
Extractos celulares
|
US20100021904A1
(en)
*
|
2008-05-21 |
2010-01-28 |
Pierce Niles A |
Shielded cross-linking probes
|
WO2009143241A2
(en)
*
|
2008-05-21 |
2009-11-26 |
Bioe, Inc. |
Differentiation of multi-lineage progenitor cells to pancreatic cells
|
US20100021901A1
(en)
*
|
2008-05-22 |
2010-01-28 |
Peng Yin |
Compositions and methods for detecting analytes
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
US8632768B2
(en)
*
|
2008-05-30 |
2014-01-21 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US11291686B2
(en)
|
2008-05-30 |
2022-04-05 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
PE20110399A1
(es)
|
2008-08-20 |
2011-06-22 |
Anthrogenesis Corp |
Tratamiento de la apoplejia utilizando celulas placentarias aisladas
|
CA2734236C
(en)
|
2008-08-20 |
2020-08-25 |
Anthrogenesis Corporation |
Improved cell composition and methods of making the same
|
NZ591293A
(en)
|
2008-08-22 |
2012-10-26 |
Anthrogenesis Corp |
Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs)
|
EP2353008A2
(de)
|
2008-09-22 |
2011-08-10 |
Oregon Health and Science University |
Verfahren zum nachweis einer infektion mit mycobacterium tuberculosis
|
WO2010037041A2
(en)
|
2008-09-26 |
2010-04-01 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
JP5836125B2
(ja)
|
2008-10-16 |
2015-12-24 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
高分子量メラノーマ関連抗原に対する完全ヒト抗体およびその使用
|
NZ602455A
(en)
|
2008-11-19 |
2014-03-28 |
Anthrogenesis Corp |
Amnion derived adherent cells
|
BRPI0921999B8
(pt)
*
|
2008-11-21 |
2021-05-25 |
Anthrogenesis Corp |
uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
|
CA2743255C
(en)
*
|
2008-12-03 |
2014-02-18 |
Andrew Pecora |
Infarct area perfusion-improving compositions and methods of vascular injury repair
|
CA2747418A1
(en)
|
2008-12-16 |
2010-07-01 |
Onconova Therapeutics, Inc. |
Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents
|
US8664183B2
(en)
|
2009-02-27 |
2014-03-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
SPANX-B polypeptides and their use
|
US20100239539A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Sing George L |
Methods for promoting differentiation and differentiation efficiency
|
AU2010266263B2
(en)
*
|
2009-07-02 |
2016-05-19 |
Celularity Inc. |
Method of producing erythrocytes without feeder cells
|
WO2011008348A2
(en)
|
2009-07-15 |
2011-01-20 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
DK2456853T3
(da)
|
2009-07-21 |
2021-02-01 |
Abt Holding Co |
Anvendelse af stamceller til reduktion af leukocyt-ekstravasation
|
DK2462230T3
(en)
*
|
2009-08-03 |
2015-10-19 |
Recombinetics Inc |
METHODS AND COMPOSITIONS FOR TARGETED RE-MODIFICATION
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
EP2499240A1
(de)
|
2009-11-12 |
2012-09-19 |
Vbi Technologies, LLC |
Subpopulationen von sporenartigen zellen und verwendungen davon
|
US9173930B2
(en)
|
2009-11-20 |
2015-11-03 |
Oregon Health & Science University |
Methods for detecting a mycobacterium tuberculosis infection
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
CA2787992A1
(en)
|
2010-01-26 |
2011-08-04 |
Anthrogenesis Corporation |
Treatment of bone-related cancers using placental stem cells
|
EP2539436B1
(de)
|
2010-02-25 |
2021-09-22 |
ABT Holding Company |
Modulierung einer makrophagen-aktivierung
|
JP2013530929A
(ja)
|
2010-04-01 |
2013-08-01 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
frizzled結合剤およびその使用
|
KR20200047797A
(ko)
|
2010-04-07 |
2020-05-07 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 혈관신생
|
CN102933221A
(zh)
|
2010-04-08 |
2013-02-13 |
人类起源公司 |
使用胎盘干细胞治疗结节病
|
EP3730943A1
(de)
|
2010-04-08 |
2020-10-28 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Zellenassay mit b-zellen-antigenen
|
US9746459B2
(en)
|
2010-04-08 |
2017-08-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antigen presenting cell assay
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US20110262406A1
(en)
|
2010-04-21 |
2011-10-27 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
JP5841322B2
(ja)
|
2010-04-22 |
2016-01-13 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
フマリルアセト酢酸ヒドロラーゼ(fah)欠損性ブタおよびその使用
|
PT2561078T
(pt)
|
2010-04-23 |
2018-12-03 |
Cold Spring Harbor Laboratory |
Sharn com uma conceção estrutural inovadora
|
WO2011138687A2
(en)
|
2010-05-06 |
2011-11-10 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
CA2802087A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
WO2011159835A1
(en)
|
2010-06-16 |
2011-12-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Antibodies to endoplasmin and their use
|
CA2804595C
(en)
|
2010-07-07 |
2018-11-13 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
KR20230096132A
(ko)
|
2010-07-13 |
2023-06-29 |
셀룰래리티 인코포레이티드 |
천연 킬러 세포의 생성 방법
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
CA2807944C
(en)
|
2010-08-12 |
2020-02-18 |
Fate Therapeutics, Inc. |
Improved hematopoietic stem and progenitor cell therapy
|
US8895291B2
(en)
|
2010-10-08 |
2014-11-25 |
Terumo Bct, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
US8574899B2
(en)
|
2010-12-22 |
2013-11-05 |
Vladimir B Serikov |
Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
|
EP2658971A1
(de)
|
2010-12-28 |
2013-11-06 |
XOMA Technology Ltd. |
Zelloberflächendisplay mit pdz-domänen
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
WO2012109208A2
(en)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
WO2012145469A1
(en)
|
2011-04-19 |
2012-10-26 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
ES2707579T3
(es)
|
2011-06-01 |
2019-04-04 |
Celularity Inc |
Tratamiento del dolor usando citoblastos placentarios
|
JP6182135B2
(ja)
|
2011-06-06 |
2017-08-16 |
レゲネシス ベーフェーベーアー |
中空繊維バイオリアクター中での幹細胞の増幅
|
KR101528440B1
(ko)
|
2011-06-10 |
2015-06-26 |
블루버드 바이오, 인코포레이티드. |
부신백질이영양증 및 부신척수신경병증을 위한 유전자 요법 벡터
|
WO2013012674A1
(en)
|
2011-07-15 |
2013-01-24 |
The General Hospital Corporation |
Methods of transcription activator like effector assembly
|
DK2747551T3
(da)
|
2011-08-26 |
2020-05-18 |
Yecuris Corp |
Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
BR112014007029A2
(pt)
|
2011-09-23 |
2017-04-11 |
Bluebird Bio Inc |
métodos aperfeiçoados de terapia gênica
|
KR102011532B1
(ko)
|
2011-09-30 |
2019-08-16 |
블루버드 바이오, 인코포레이티드. |
개선된 바이러스 형질도입을 위한 화합물
|
EP3381456A1
(de)
|
2011-12-02 |
2018-10-03 |
Fate Therapeutics, Inc. |
Verbesserte verfahren zur behandlung von ischämie
|
CA2857640C
(en)
|
2011-12-02 |
2021-11-16 |
Fate Therapeutics, Inc. |
Enhanced stem cell composition
|
TWI443107B
(zh)
|
2011-12-29 |
2014-07-01 |
Ind Tech Res Inst |
人源化之抗人類細胞表面抗原cd34之單株抗體及其應用
|
WO2013138643A1
(en)
|
2012-03-16 |
2013-09-19 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Soluble engineered monomeric fc
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
SG11201407972RA
(en)
|
2012-06-01 |
2015-01-29 |
Us Health |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
EP3492084B1
(de)
|
2012-08-01 |
2021-02-17 |
United Therapeutics Corporation |
Behandlung von lungenarterienhochdruck mit prostacyclinbehandelten endothelvorläuferzellen
|
JP6901823B2
(ja)
|
2012-08-01 |
2021-07-14 |
ユナイテッド セラピューティクス コーポレイション |
間葉系幹細胞による肺動脈性高血圧症の処置
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
CN105026429B
(zh)
|
2012-08-21 |
2018-09-25 |
美国政府(由卫生和人类服务部的部长所代表) |
间皮素结构域-特异性单克隆抗体及其用途
|
JP6307085B2
(ja)
|
2012-09-27 |
2018-04-04 |
ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズThe United States of America,as represented by the Secretary,Department of Health and Human Services |
メソテリン抗体および強力な抗腫瘍活性を惹起するための方法
|
JP2015536933A
(ja)
|
2012-10-23 |
2015-12-24 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路結合剤を用いて神経内分泌腫瘍を処置する方法
|
CN109554350B
(zh)
|
2012-11-27 |
2022-09-23 |
儿童医疗中心有限公司 |
用于胎儿血红蛋白再诱导的靶向bcl11a远端调控元件
|
US11007385B2
(en)
|
2012-12-10 |
2021-05-18 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
ES2963968T3
(es)
|
2013-01-09 |
2024-04-03 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
US9783783B2
(en)
|
2013-01-30 |
2017-10-10 |
Cornell University |
Compositions and methods for the expansion of stem cells
|
AU2014212081A1
(en)
|
2013-02-04 |
2015-08-13 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
EP3622960A1
(de)
|
2013-02-05 |
2020-03-18 |
Celularity, Inc. |
Natürliche killerzellen aus plazenta
|
WO2014130770A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
WO2014150602A1
(en)
|
2013-03-15 |
2014-09-25 |
Fate Therapeutics, Inc. |
Cell potency assay for therapeutic potential
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
AU2014248167B2
(en)
|
2013-04-03 |
2019-10-10 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for culturing endoderm progenitor cells in suspension
|
PL2983680T3
(pl)
|
2013-04-12 |
2021-03-08 |
Houston Methodist Hospital |
Ulepszanie narządów do przeszczepu
|
EP2992088B1
(de)
|
2013-04-30 |
2019-08-21 |
Katholieke Universiteit Leuven |
Zelltheraphie für myelodysplastische syndrome
|
US9758763B2
(en)
|
2013-05-29 |
2017-09-12 |
The Regents Of The University Of California |
Methods and compositions for somatic cell proliferation and viability
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
EP3057973B1
(de)
|
2013-10-15 |
2019-09-04 |
Case Western Reserve University |
Zusammensetzungen mit einem 15-pgdh-hemmer zur wundheilung
|
US9617506B2
(en)
|
2013-11-16 |
2017-04-11 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015109180A2
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3613841B1
(de)
|
2014-03-25 |
2022-04-20 |
Terumo BCT, Inc. |
Passives ersetzen von medien
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
AU2015249381B2
(en)
|
2014-04-25 |
2020-04-30 |
Children's Medical Center Corporation |
Compositions and methods to treating hemoglobinopathies
|
WO2015172153A1
(en)
|
2014-05-09 |
2015-11-12 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
TWI654202B
(zh)
|
2014-05-27 |
2019-03-21 |
中央研究院 |
增進抗體功效之通用糖型之組合物及方法
|
AU2015267047A1
(en)
|
2014-05-27 |
2017-01-05 |
Academia Sinica |
Anti-CD20 glycoantibodies and uses thereof
|
CA2950440A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267044A1
(en)
|
2014-05-28 |
2016-12-15 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
US11278572B2
(en)
|
2014-07-18 |
2022-03-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
ES2925224T3
(es)
|
2014-07-31 |
2022-10-14 |
Us Gov Health & Human Services |
Anticuerpos monoclonales humanos contra EphA4 y su uso
|
CA2960712A1
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Human inkt cell activation using glycolipids
|
US11142577B2
(en)
|
2014-09-12 |
2021-10-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
WNT signaling agonist molecules
|
CN106715676A
(zh)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
按计划供养
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2016118191A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
EP3250682A4
(de)
|
2015-01-26 |
2018-08-01 |
Fate Therapeutics, Inc. |
Zellen mit erhöhten immunregulatorischen eigenschaften und verfahren zu deren verwendung und herstellung
|
WO2016182917A1
(en)
|
2015-05-08 |
2016-11-17 |
Children's Medical Center Corporation |
Targeting bcl11a enhancer functional regions for fetal hemoglobin reinduction
|
EP3297672B1
(de)
|
2015-05-21 |
2021-09-01 |
Harpoon Therapeutics, Inc. |
Trispezifische bindungsproteine und verfahren zur verwendung
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
EP3325612B1
(de)
|
2015-07-20 |
2022-12-14 |
Angiocrine Bioscience, Inc. |
Verfahren und zusammensetzungen für stammzelltransplantation
|
EP3324982A4
(de)
|
2015-07-21 |
2019-01-09 |
The Children's Medical Center Corporation |
Hämatopoietische stammzellen exprimierendes pd-l1 und verwendungen
|
US11312940B2
(en)
|
2015-08-31 |
2022-04-26 |
University Of Louisville Research Foundation, Inc. |
Progenitor cells and methods for preparing and using the same
|
CN108350605A
(zh)
|
2015-09-04 |
2018-07-31 |
台湾浩鼎生技股份有限公司 |
聚糖阵列以及使用方法
|
US11207393B2
(en)
|
2015-10-16 |
2021-12-28 |
President And Fellows Of Harvard College |
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
|
AU2017217813B2
(en)
|
2016-02-12 |
2023-08-03 |
Bluebird Bio, Inc. |
VCN enhancer compositions and methods of using the same
|
WO2017139561A1
(en)
|
2016-02-12 |
2017-08-17 |
Bluebird Bio, Inc. |
Vcn enhancer compositions and methods of using the same
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
US11072777B2
(en)
|
2016-03-04 |
2021-07-27 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
CA3018332A1
(en)
|
2016-03-21 |
2017-09-28 |
Dana-Farber Cancer Institute, Inc. |
T-cell exhaustion state-specific gene expression regulators and uses thereof
|
US20200299649A1
(en)
|
2016-03-29 |
2020-09-24 |
Smsbiotech, Inc. |
Compositions and methods for using small mobile stem cells
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
BR112018070097A2
(pt)
|
2016-03-29 |
2019-02-12 |
Obi Pharma, Inc. |
anticorpo, hibridoma, composição farmacêutica, método para tratar câncer em um indivíduo, método para inibir a proliferação de células cancerígenas, método para diagnosticar o câncer em um indivíduo, método para tratar um paciente humano, método para fazer imagens de um indivíduo, conjugado de fármaco-anticorpo (adc), método para tratar câncer, anticorpo biespecífico e método para preparar uma população de anticorpos homogêneos
|
SG11201809024UA
(en)
|
2016-04-22 |
2018-11-29 |
Obi Pharma Inc |
Cancer immunotherapy by immune activation or immune modulation via globo series antigens
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
JP7101621B2
(ja)
|
2016-05-20 |
2022-07-15 |
ハープーン セラピューティクス,インク. |
単一ドメイン血清アルブミン結合タンパク質
|
KR102365977B1
(ko)
|
2016-05-20 |
2022-02-22 |
하푼 테라퓨틱스, 인크. |
단일 쇄 가변 단편 cd3 결합 단백질
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
ES2908919T3
(es)
|
2016-07-05 |
2022-05-04 |
California Inst Of Techn |
Reacción en cadena de hibridación de iniciador fraccionario
|
CN110072545A
(zh)
|
2016-07-27 |
2019-07-30 |
台湾浩鼎生技股份有限公司 |
免疫原性/治疗性聚糖组合物及其用途
|
KR102528998B1
(ko)
|
2016-07-29 |
2023-05-03 |
오비아이 파머 인코퍼레이티드 |
인간 항체, 제약 조성물 및 방법
|
WO2018026533A1
(en)
|
2016-08-02 |
2018-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies targeting glypican-2 (gpc2) and use thereof
|
EP3500594A4
(de)
|
2016-08-22 |
2020-03-11 |
Cho Pharma Inc. |
Antikörper, bindungsfragmente und verfahren zur verwendung
|
CA3034617A1
(en)
|
2016-08-30 |
2018-03-08 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
AU2017350732B2
(en)
|
2016-10-24 |
2023-07-27 |
United Therapeutics Corporation |
Enhancement of MSC immunomodulatory properties by treprostinil
|
TWI822055B
(zh)
|
2016-11-21 |
2023-11-11 |
台灣浩鼎生技股份有限公司 |
共軛生物分子、醫藥組成物及方法
|
BR112019010602A2
(pt)
|
2016-11-23 |
2019-12-17 |
Harpoon Therapeutics Inc |
proteínas trispecíficas para psma e métodos de uso
|
EP3544997A4
(de)
|
2016-11-23 |
2020-07-01 |
Harpoon Therapeutics, Inc. |
Prostataspezifisches membranantigenbindendes proteine
|
WO2018102552A1
(en)
|
2016-11-30 |
2018-06-07 |
Case Western Reserve University |
Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
|
CA3045902A1
(en)
|
2016-12-21 |
2018-06-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for flt3 and uses thereof
|
AU2018215678A1
(en)
|
2017-02-06 |
2019-08-22 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
AU2018221730A1
(en)
|
2017-02-15 |
2019-08-29 |
2Seventy Bio, Inc. |
Donor repair templates multiplex genome editing
|
US11535668B2
(en)
|
2017-02-28 |
2022-12-27 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
US11261441B2
(en)
|
2017-03-29 |
2022-03-01 |
Bluebird Bio, Inc. |
Vectors and compositions for treating hemoglobinopathies
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
US11702634B2
(en)
|
2017-03-31 |
2023-07-18 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
JP2020518275A
(ja)
|
2017-05-03 |
2020-06-25 |
バイオマリン ファーマシューティカル インコーポレイテッド |
造血幹細胞の形質導入のための改善されたレンチウイルス
|
JP7090347B2
(ja)
|
2017-05-12 |
2022-06-24 |
ハープーン セラピューティクス,インク. |
メソテリン結合タンパク質
|
EP3621648A4
(de)
|
2017-05-12 |
2021-01-20 |
Harpoon Therapeutics, Inc. |
Auf trispezifische proteine abzielendes msln und verfahren zur verwendung
|
EP3625256A1
(de)
|
2017-05-19 |
2020-03-25 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Humaner monoklonaler antikörper gegen tnfr2 zur krebsimmuntherapie
|
WO2018218135A1
(en)
|
2017-05-25 |
2018-11-29 |
The Children's Medical Center Corporation |
Bcl11a guide delivery
|
BR112019024291A2
(pt)
|
2017-06-09 |
2020-07-28 |
Providence Health & Services-Oregon |
utilização de cd39 e de cd103 para a identificação de células t tumorais humanas reativas para o tratamento do câncer
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY
|
CA3066953A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
Human monoclonal antibodies specific for cd33 and methods of their use
|
WO2019060708A1
(en)
|
2017-09-22 |
2019-03-28 |
The Children's Medical Center Corporation |
TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS
|
AU2018346955A1
(en)
|
2017-10-13 |
2020-04-30 |
Harpoon Therapeutics, Inc. |
B cell maturation antigen binding proteins
|
CN111630070A
(zh)
|
2017-10-13 |
2020-09-04 |
哈普恩治疗公司 |
三特异性蛋白质及使用方法
|
TW202035444A
(zh)
|
2018-06-27 |
2020-10-01 |
台灣浩鼎生技股份有限公司 |
用於糖蛋白工程的糖苷合成酶變體及其使用方法
|
WO2020006273A1
(en)
|
2018-06-27 |
2020-01-02 |
Juvena Therapeutics, Inc. |
Heparin-associated polypeptides and uses thereof
|
JP7459043B2
(ja)
|
2018-07-12 |
2024-04-01 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
親和性成熟cd22特異的モノクローナル抗体およびその使用
|
US20210292428A1
(en)
|
2018-08-08 |
2021-09-23 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
High affinity monoclonal antibodies targeting glypican-2 and uses thereof
|
EP3844287B1
(de)
|
2018-08-31 |
2024-05-22 |
Yale University |
Zusammensetzungen und verfahren zur verbesserung der oligonukleotidbasierten geneditierung
|
US20210338815A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
JP7425049B2
(ja)
|
2018-09-25 |
2024-01-30 |
ハープーン セラピューティクス,インク. |
Dll3結合タンパク質および使用方法
|
MX2021003779A
(es)
|
2018-10-02 |
2021-09-21 |
Immunome Inc |
Anticuerpos dirigidos a la epn1.
|
US20210340562A1
(en)
|
2018-10-19 |
2021-11-04 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use
|
JOP20210115A1
(ar)
|
2018-11-21 |
2023-01-30 |
Univ Texas |
تركيبات وطرق لتعديل نشاط ديهيدروجيناز بسلسلة قصيرة
|
US20210380950A1
(en)
|
2018-11-28 |
2021-12-09 |
Milica Radisic |
Methods for tissue generation
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
US20220064324A1
(en)
|
2019-01-08 |
2022-03-03 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting mesothelin for treating solid tumors
|
EP3883971A1
(de)
|
2019-01-22 |
2021-09-29 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hochaffine monoklonale antikörper gegen glypican-1 und verfahren zur verwendung
|
JP2022533957A
(ja)
|
2019-05-14 |
2022-07-27 |
ハープーン セラピューティクス,インク. |
EpCAM結合タンパク質および使用方法
|
US20210008161A1
(en)
|
2019-06-17 |
2021-01-14 |
Crispr Therapeutics Ag |
Methods and compositions for improved homology directed repair
|
US20220243211A1
(en)
|
2019-06-21 |
2022-08-04 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
US20230227583A1
(en)
|
2019-08-30 |
2023-07-20 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
US20220380471A1
(en)
|
2019-10-22 |
2022-12-01 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
High affinity nanobodies targeting b7-h3 (cd276) for treating multiple solid tumors
|
JP2023527609A
(ja)
|
2020-02-21 |
2023-06-30 |
ハープーン セラピューティクス,インク. |
Flt3結合タンパク質および使用方法
|
CA3183262A1
(en)
|
2020-05-20 |
2021-11-25 |
Rodeo Therapeutics Corporation |
Compositions and methods of modulating short-chain dehydrogenase activity
|
AU2021331785A1
(en)
|
2020-08-31 |
2023-03-30 |
Gennao Bio, Inc. |
Compositions and methods for delivery of nucleic acids to cells
|
US20230391852A1
(en)
|
2020-10-26 |
2023-12-07 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
AU2021400745A1
(en)
|
2020-12-17 |
2023-07-20 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
|
WO2022164796A1
(en)
|
2021-01-26 |
2022-08-04 |
California Institute Of Technology |
Allosteric conditional guide rnas for cell-selective regulation of crispr/cas
|
EP4319800A1
(de)
|
2021-04-07 |
2024-02-14 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen und verfahren zur behandlung von krebs
|
WO2022232612A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
KR20240049794A
(ko)
|
2021-06-07 |
2024-04-17 |
프로비던스 헬스 앤드 서비시즈 - 오레곤 |
Cxcr5, pd-1, 및 icos 발현 종양 반응성 cd4 t 세포 및 그의 용도
|
CA3216228A1
(en)
|
2021-06-09 |
2022-12-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting pd-l1 for treating solid tumors
|
AU2022345251A1
(en)
|
2021-09-17 |
2024-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodies
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2024020597A1
(en)
|
2022-07-22 |
2024-01-25 |
The Johns Hopkins University |
Dendrimer-enabled targeted intracellular crispr/cas system delivery and gene editing
|
WO2024050399A1
(en)
|
2022-09-01 |
2024-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|
WO2024081736A2
(en)
|
2022-10-11 |
2024-04-18 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|